Study to Evaluate Safety and Immunogenicity of COVID-19 Vaccine in Children 6 Months to < 12 Years
Clinical trial NCT05468736 · COMPLETED
Trial details
- NCT number
- NCT05468736
- Sponsor
- Novavax
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-07-22
- Primary completion
- 2024-01-16
- Enrollment
- 3600
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.